The invention discloses a method for determining the
plasma protein binding rate of a polypeptide coupled
radionuclide drug, which comprises the following steps: S1, unfreezing cryopreserved blank
plasma in cold water, centrifuging to remove upper and bottom substances, and determining the pH value of the
plasma; diluting the
test solution to a proper concentration, taking blank plasma, adding the blank plasma into the
test solution, fully mixing to obtain a
plasma sample with the required concentration, and incubating the
plasma sample in a constant-temperature water bath at 37 DEG C for a certain time; s2, adding a
trichloroacetic acid solution with a certain concentration into the
test tube, centrifuging and collecting supernate; adding a
trichloroacetic acid solution with a certain concentration into the precipitate, centrifugally collecting supernate, repeating the step for several times, merging the collected supernate, and separately collecting the precipitate; and S3, respectively measuring radioactivity counts of the background, the supernatant and the precipitate by using a gamma-counter, and calculating the plasma
protein binding rate of the
medicine: PPB (%) = (precipitate count-background count) / [(precipitate count-background count) + supernatant count-background count)] * 100%.